Intervention not reported
Para/propacetamol vs placebo see footnote1 · patients with postoperative pain
The intervention probably leads to higher para/propacetamol vs placebo see footnote1 (moderate certainty).
1 finding from 1 review
Intervention not reported
Paracetamol vs placebo see footnote1 · patients with postoperative pain
The intervention probably leads to higher paracetamol vs placebo see footnote1 (moderate certainty).
1 finding from 1 review
Intervention not reported
Topical diclofenac gel or solution Clinical success (for example 50% reduction in pain) · adults with chronic musculoskeletal pain (osteoarthritis)
1 finding from 1 review
Intervention not reported
Topical ketoprofen gel Clinical success (for example 50% reduction in pain) · adults with chronic musculoskeletal pain (osteoarthritis)
1 finding from 1 review
Intervention not reported
Topical diclofenac gel or solution Local adverse events · adults with chronic musculoskeletal pain (osteoarthritis)
1 finding from 1 review
Intervention not reported
Topical ketoprofen gel Local adverse events · adults with chronic musculoskeletal pain (osteoarthritis)
1 finding from 1 review
Intervention not reported
Systemic adverse events · adults with chronic musculoskeletal pain (osteoarthritis)
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Intervention not reported
Serious adverse events · adults with chronic musculoskeletal pain (osteoarthritis)
1 finding from 1 review
no estimate extracted
30 participants
Very low
Fatigue · patients with cancer‐related fatigue (adults)
Educational interventions showed no clear difference in general fatigue (at the end of the educational intervention) compared with control (usual care or attention control) (low certainty).
2 findings from 1 review
Fatigue distress (at the end of the educational intervention) · patients with cancer‐related fatigue (adults)
Educational interventions showed no clear difference in fatigue distress (at the end of the educational intervention) compared with control (usual care or attention control) (low certainty).
1 finding from 1 review
Fatigue interference (at the end of the educational intervention) · patients with cancer‐related fatigue (adults)
Educational interventions showed no clear difference in fatigue interference (at the end of the educational intervention) compared with control (usual care or attention control) (moderate certainty).
1 finding from 1 review
Anxiety · patients with cancer‐related fatigue (adults)
Educational interventions showed no clear difference in anxiety (at the end of the educational intervention) compared with control (usual care or attention control) (low certainty).
1 finding from 1 review
Depression (at the end of the educational intervention) · patients with cancer‐related fatigue (adults)
It is very uncertain whether educational interventions changes depression (at the end of the educational intervention) compared with control (usual care or attention control) (very low certainty).
1 finding from 1 review
Global quality of life (at the end of the educational intervention) · patients with cancer‐related fatigue (adults)
Educational interventions showed no clear difference in global quality of life (at the end of the educational intervention) compared with control (usual care or attention control) (low certainty).
1 finding from 1 review
Pain‐free response at 2 h for moderate to severe baseline pain · adults with migraine headache ‐ moderate or severe and mild baseline pain
1 finding from 1 review
no estimate extracted
Studies not reported
High
Pain‐free response at 2 h for mild baseline pain · adults with migraine headache ‐ moderate or severe and mild baseline pain
1 finding from 1 review
no estimate extracted
Studies not reported
High
Headache relief at 2 h for moderate to severe baseline pain · adults with migraine headache ‐ moderate or severe and mild baseline pain
1 finding from 1 review
no estimate extracted
Studies not reported
High
Sustained pain‐free during the 24 h post dose for moderate to severe baseline pain · adults with migraine headache ‐ moderate or severe and mild baseline pain
1 finding from 1 review
no estimate extracted
Studies not reported
Moderate
Sustained pain‐free during the 24 h post dose for mild baseline pain · adults with migraine headache ‐ moderate or severe and mild baseline pain
1 finding from 1 review
no estimate extracted
Studies not reported
High
Sustained headache relief during the 24 h post dose for moderate or severe baseline pain · adults with migraine headache ‐ moderate or severe and mild baseline pain
1 finding from 1 review
no estimate extracted
Studies not reported
High